Skip to content

support@abbonews.com

Menu

US Markets
Business
Technology
News
Featured
Press Release

US Markets
Business
Technology
News
Featured
Press Release

US Markets
Business
Technology
News
Featured
Press Release

BioNTech

BioNTech

BioNTech (NASDAQ: BNTX) Q2 Losses Quadruple Amid Strategic Shift to Cancer Drugs

Mark Glenn / 5 August 2024

BERLIN – Losses at Germany’s BioNTech (NASDAQ: BNTX) quadrupled year-on-year in the second quarter, the company said on Monday, as […]

BioNTech (NASDAQ: BNTX) Q2 Losses Quadruple Amid Strategic Shift to Cancer Drugs Read More »

BioNTech

BioNTech’s (NASDAQ: BNTX) Cancer Drug Meets Primary Endpoint in Phase 2 Trial

Edward Cooke / 30 July 2024

On Tuesday, BioNTech (NASDAQ: BNTX), the maker of the COVID-19 vaccine, said that its cancer drug candidate BNT111 significantly improved

BioNTech’s (NASDAQ: BNTX) Cancer Drug Meets Primary Endpoint in Phase 2 Trial Read More »

Company

About Us

Team

Contact Us

Categories

US Market

Business

Technology

News

Featured

Press Release

Legal

Privacy Policy

Disclaimer

Copyright © 2024 abbonews.com.